Another example of CTLA-4 combination treatment enhancing efficacy pertains to targeting mutations in Breast Cancer genes1/2 (BRCA1/2), which are genes involved in DNA repair (Fig. 2) [84]. This evidence concerns the gene CTLA4 and breast carcinoma.